- Adjusted EBITDA: JBS reports a significant increase in adjusted EBITDA, reaching R$11.94 billion compared to R$5.41 billion in the same quarter last year. This is higher than the estimated R$10.05 billion.
- Net Income: The company’s net income rises to R$3.84 billion from R$572.7 million year-over-year, though it slightly misses the estimate of R$4.12 billion.
- Net Revenue Growth: JBS’s net revenue increases by 21% year-over-year to R$110.50 billion, surpassing expectations of R$107.62 billion.
- EBITDA Figures: EBITDA is reported at R$11.63 billion, a notable improvement from R$5.23 billion in the previous year.
- Dividend Approval: The company has approved intermediate dividends amounting to R$2.22 billion.
- Future EBITDA Expectations: JBS anticipates EBITDA for 2024 to be between US$6.9 billion and US$7.1 billion.
- 2024 Revenue Projection: The company estimates its net revenue to be US$77 billion in 2024.
- Analyst Recommendations: There are 19 buy ratings for JBS, with no hold or sell recommendations.
A look at JBS S/A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, JBS S/A shows a mixed long-term outlook. The company receives a good score for dividends and momentum, indicating a strong payout to shareholders and positive market momentum. However, JBS S/A scores lower in terms of growth and resilience, reflecting potential challenges in expanding its business and withstanding adverse market conditions. The company’s value score falls in the middle range, suggesting that it may offer potential for investors but is not deeply undervalued. Overall, JBS S/A, a meat processing company that exports products globally, presents a varied picture in terms of its future prospects.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
